# Psychiatric Orders in Psychoanalytic Treatment of ASD

> **NCT05930912** · — · UNKNOWN · sponsor: **Yang I. Pachankis, PhD** · enrollment: 1 (actual)

## Conditions studied

- PTSD
- Autism Spectrum Disorder High-Functioning
- OCD
- Agoraphobia With Panic Attacks
- Depression, Unipolar
- Depression, Anxiety
- Depression and Suicide
- Depression, Reactive
- Depression; Psychoneurotic
- Depression Anxiety Disorder
- Panic Disorder With Agoraphobia, Severe Agoraphobic Avoidance and Mild Panic Attacks
- Anxiety Disorders
- ADHD - Combined Type
- Borderline Personality Disorder
- Social Anxiety Disorder
- Avoidant Personality Disorder
- Stockholm Syndrome
- Grief
- Separation Insecurity

## Interventions

- **DIAGNOSTIC_TEST:** Psychoanalysis
- **DRUG:** sertraline 50mg
- **DRUG:** Duloxetine 20 MG
- **BEHAVIORAL:** Cognitive Behavioral Therapy

## Key facts

- **NCT ID:** NCT05930912
- **Lead sponsor:** Yang I. Pachankis, PhD
- **Sponsor class:** INDIV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05930912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05930912, "Psychiatric Orders in Psychoanalytic Treatment of ASD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05930912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*